Statins linked with lower mortality in ankylosing spondylitis

Patients with ankylosing spondylitis may live longer if they take a statin, a Harvard University study suggests.

Matching 1108 patients with ankylosing spondylitis who initiated statins with the same number of people who did not take statins, revealed those taking the medications had a 37% lower all-cause mortality rate over a mean follow-up of 5.2 years.

The surprisingly large effect was greater than the 9-14% mortality benefit seen in meta-analyses of statins in the general population and also greater than the benefit of statins in rheumatoid arthritis, a population known to be at